Artificial Heart: Man (*100*) 100 days with artificial titanium heart in a first for medical science |

BiVACOR titanium heart (Credit: X)

An Australian man in his 40s has made historical past by surviving 100 days with an artificial titanium heart earlier than receiving a donor transplant, marking a important breakthrough in heart failure remedy, experiences CNN.
The man was implanted with the BiVACOR complete artificial heart at St Vincent’s Hospital Sydney in November. He grew to become the first individual in the world to be discharged from hospital with the system, which saved him alive till a donor heart grew to become out there in early March.
The BiVACOR heart
Developed by Australian bioengineer Dr Daniel Timms, the BiVACOR heart is the first absolutely implantable rotary blood pump designed to switch a human heart. Unlike conventional artificial hearts, it makes use of magnetic levitation expertise to imitate pure blood movement, with a single transferring half—a levitated rotor held in place by magnets—lowering put on and tear.
Timms, who created the system after his father’s dying from heart illness, advised CNN that stated it was “exhilarating to see decades of work come to fruition.” He added, “The entire BiVACOR team is deeply grateful to the patient and his family for placing their trust in our Total Artificial Heart. Their bravery will pave the way for countless more patients to receive this lifesaving technology.”
The system was implanted in a six-hour process led by cardiothoracic and transplant surgeon Dr Paul Jansz. The affected person, who wished to stay nameless, recovered nicely and was discharged in February earlier than receiving a donor heart in March.
Hope for heart failure sufferers
Heart failure impacts over 23 million folks worldwide, however solely about 6,000 obtain a donor heart every year. The BiVACOR artificial heart is designed as a bridge to transplant, serving to sufferers survive till a donor organ is discovered. However, researchers hope that in the longer term, the system may function a long-term different to transplantation.
Professor Chris Hayward from the Victor Chang Cardiac Research Institute known as the trial a game-changer. “The BiVACOR Total Artificial Heart ushers in a whole new ball game for heart transplants. Within the next decade, we will see the artificial heart becoming the alternative for patients who are unable to wait for a donor heart or when a donor heart is simply not available.”
The Australian authorities has invested AU$50 million in the Artificial Heart Frontiers Program, which is main trials of three completely different units to fight heart failure. The BiVACOR heart has already been examined in the United States underneath the Food and Drug Administration’s Early Feasibility Study, the place 5 sufferers obtained the implant. The longest survival time earlier than a transplant in these instances was 27 days, making the Australian trial probably the most profitable to date.